Compounds > methylprednisolone

methylprednisolone and Apoplexy, Pituitary

methylprednisolone has been researched along with Apoplexy, Pituitary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dhoot, M; Kanakpur, S; Katti, V; Ramamurthy, LB; Shet, SD1
de Otero, J; Ferrer, L; Lozano, P; Oms, B; Valldeoriola, F; Vila, L; Villegas, E1
Glaser, JS; Job, OM; Schatz, NJ1

Other Studies

3 other study(ies) available for methylprednisolone and Apoplexy, Pituitary

ArticleYear
Neuro-ophthalmic presentation of COVID-19 disease: A case report.
    Indian journal of ophthalmology, 2021, Volume: 69, Issue:4

    Topics: Adenoma; COVID-19; COVID-19 Drug Treatment; Eye Infections, Viral; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; SARS-CoV-2

2021
Meningitis by Gemella morbillorum with associated pituitary apoplexy: a case report.
    European journal of internal medicine, 2008, Volume: 19, Issue:8

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Glucocorticoids; Humans; Injections, Intravenous; Male; Meningitis; Methylprednisolone; Middle Aged; Penicillin G; Pituitary Apoplexy; Staphylococcaceae; Treatment Outcome

2008
Spontaneous resolution of pituitary adenoma after apoplexy.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2000, Volume: 20, Issue:1

    Topics: Adenoma; Fludrocortisone; Humans; Hydrocortisone; Hypopituitarism; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Remission, Spontaneous; Thyroxine

2000